BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Hoth Therapeutics Announces Positive Pre Clinical Data HT-ALZ Shows Promising Breakthrough in Alzheimer’s Disease Research Acute treatment with HT-ALZ led to a rapid (~15%) reduction in brain interstitial fluid Aβ levels, within 20 hours

  April 2, 2025

   · 

  5 min read
• Press Releases

  LinusBio and The BRAIN Foundation Partner to Advance Biomarker-Supported Autism Diagnosis and Early Intervention

  April 2, 2025

   · 

  4 min read
• 

  Press Releases

  Okogen Announces Regulatory Submission to CDSCO for EMERALD STUDY and Appointment of New Chief Medical Officer

  April 2, 2025

   · 

  2 min read
• Press Releases

  Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership

  April 2, 2025

   · 

  10 min read
• Press Releases

  University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification

  April 2, 2025

   · 

  4 min read
• Press Releases

  PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

  April 2, 2025

   · 

  1 min read
• Press Releases

  Sentynl Therapeutics Announces First Comprehensive Body of Clinical Evidence Supporting NULIBRY® (fosdenopterin) in Treating Molybdenum Cofactor Deficiency Type A Compared to Natural History

  April 2, 2025

   · 

  7 min read
• Press Releases

  Hoth Therapeutics Collaborates with Washington University on NIH Grant Application Advancing Alzheimer’s Program Using NK-1 Receptor Antagonist HT-ALZ

  April 2, 2025

   · 

  5 min read
• Press Releases

  Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025

  April 2, 2025

   · 

  5 min read
• Press Releases

  Endeavor BioMedicines Appoints Internationally Renowned ILD Expert Lisa Lancaster, M.D., as Chief Medical Officer

  April 2, 2025

   · 

  2 min read